Recent publications
The burden of malaria: understanding the balance between immunity, public health and control.Snow RW
J Med Microbiol, (2000). 49:1053-5
Using evidence to change antimalarial drug policy in Kenya.Shretta R, Omumbo J, Rapuoda B, Snow RW
Trop Med Int Health, (2000). 5:755-64
Sustainability, affordability, and equity of corporate drug donations: the case of Malarone.Shretta R, Brugha R, Robb A, Snow RW
Lancet, (2000). 355:1718-20
Changing patterns of clinical malaria since 1965 among a tea estate population located in the Kenyan highlands.Shanks GD, Biomndo K, Hay SI, Snow RW
Trans R Soc Trop Med Hyg, (2000). 94:253-5
Aetiology, outcome, and risk factors for mortality among adults with acute pneumonia in Kenya.Scott JA, Hall AJ, Muyodi C, Lowe B, Ross M, Chohan B, Mandaliya K, Getambu E, Gleeson F, Drobniewski F, Marsh K
Lancet, (2000). 355:1225-30
Validation of immune-complex enzyme immunoassays for diagnosis of pneumococcal pneumonia among adults in Kenya.Scott JA, Hall AJ, Leinonen M
Clin Diagn Lab Immunol, (2000). 7:64-7
Mapping of the region of complement receptor (CR) 1 required for Plasmodium falciparum rosetting and demonstration of the importance of CR1 in rosetting in field isolates.Rowe JA, Rogerson SJ, Raza A, Moulds JM, Kazatchkine MD, Marsh K, Newbold CI, Atkinson JP, Miller LH
J Immunol, (2000). 165:6341-6
Autoagglutination of malaria-infected red blood cells and malaria severity.Roberts DJ, Pain A, Kai O, Kortok M, Marsh K
Lancet, (2000). 355:1427-8
Relative contribution of cytochromes P-450 and flavin-containing monoxygenases to the metabolism of albendazole by human liver microsomes.Rawden HC, Kokwaro GO, Ward SA, Edwards G
Br J Clin Pharmacol, (2000). 49:313-22
Antibiotic susceptibility and genotypes of non-typhi Salmonella isolates from children in Kilifi on the Kenya coast.Oundo JO, Kariuki S, Maghenda JK, Lowe BS
Trans R Soc Trop Med Hyg, (2000). 94:212-5
The efficacy of pyrimethamine-sulfadoxine (Fansidar) in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children.Ogutu BR, Smoak BL, Nduati RW, Mbori-Ngacha DA, Mwathe F, Shanks GD
Trans R Soc Trop Med Hyg, (2000). 94:83-4
Cerebral malaria.Newton CR, Hien TT, White N
J Neurol Neurosurg Psychiatry, (2000). 69:433-41
Molecular evidence of greater selective pressure for drug resistance exerted by the long-acting antifolate Pyrimethamine/Sulfadoxine compared with the shorter-acting chlorproguanil/dapsone on Kenyan Plasmodium falciparum.Nzila AM, Nduati E, Mberu EK, Hopkins Sibley C, Monks SA, Winstanley PA, Watkins WM
J Infect Dis, (2000). 181:2023-8
Towards an understanding of the mechanism of pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: genotyping of dihydrofolate reductase and dihydropteroate synthase of Kenyan parasites.Nzila AM, Mberu EK, Sulo J, Dayo H, Winstanley PA, Sibley CH, Watkins WM
Antimicrob Agents Chemother, (2000). 44:991-6
Forecasting disease risk for increased epidemic preparedness in public health.Myers MF, Rogers DJ, Cox J, Flahault A, Hay SI
Adv Parasitol, (2000). 47:309-30
Analysis of plasmid and chromosomal DNA of multidrug-resistant Salmonella enterica serovar typhi from Asia.Mirza S, Kariuki S, Mamun KZ, Beeching NJ, Hart CA
J Clin Microbiol, (2000). 38:1449-52
The changing in vitro susceptibility pattern to pyrimethamine/sulfadoxine in Plasmodium falciparum field isolates from Kilifi, Kenya.Mberu EK, Mosobo MK, Nzila AM, Kokwaro GO, Sibley CH, Watkins WM
Am J Trop Med Hyg, (2000). 62:396-401
Age patterns in stunting and anaemia in African schoolchildren: a cross-sectional study in Tanzania.Lwambo NJ, Brooker S, Siza JE, Bundy DA, Guyatt H
Eur J Clin Nutr, (2000). 54:36-40
Genotypic analysis of multidrug-resistant Salmonella enterica Serovar typhi, Kenya.Kariuki S, Gilks C, Revathi G, Hart CA
Emerg Infect Dis, (2000). 6:649-51
Genotypes of multidrug-resistant Salmonella enterica serotype typhimurium from two regions of Kenya.Kariuki S, Oundo JO, Muyodi J, Lowe B, Threlfall EJ, Hart CA
FEMS Immunol Med Microbiol, (2000). 29:9-13